Most recently, we reported upregulated plasma and tumor tissue expression of NRP-1 in breast cancer cases with advanced nodal and metastatic disease, and particularly in triple negative breast cancer compared to other molecular subtypes [4]. The gene discussed is NRP1; the disease is breast carcinoma.